Targeted therapies include endocrine therapy, molecular targeted therapy, and monoclonal antibodies like trastuzumab for human epidermal growth factor receptor 2 (HER2) positive breast cancer [13,14]. The gene discussed is ERBB2; the disease is breast carcinoma.